These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10394459)

  • 1. [Iron supplementation in preterm infants treated with erythropoietin].
    Picaud JC; Putet G; Salle BL; Claris O
    Arch Pediatr; 1999 Jun; 6(6):657-64. PubMed ID: 10394459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin.
    Meyer MP; Haworth C; Meyer JH; Commerford A
    J Pediatr; 1996 Aug; 129(2):258-63. PubMed ID: 8765624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose intravenous iron administration in chronic hemodialysis patients treated with recombinant human erythropoietin.
    Harmankaya O; Eran A
    Ren Fail; 2002 Mar; 24(2):245-7. PubMed ID: 12071600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants.
    Pollak A; Hayde M; Hayn M; Herkner K; Lombard KA; Lubec G; Weninger M; Widness JA
    Pediatrics; 2001 Jan; 107(1):78-85. PubMed ID: 11134438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of available intravenous iron preparations in hemodialysis.
    Palmer K; Cameron K; Battistella M
    CANNT J; 2013; 23(2):51-4; quiz 55-6. PubMed ID: 24069699
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous iron supplementation in end-stage renal disease patients.
    Matzke GR
    Am J Kidney Dis; 1999 Mar; 33(3):595-7. PubMed ID: 10070926
    [No Abstract]   [Full Text] [Related]  

  • 7. The safety of intravenous iron sucrose use in the elderly patient.
    Reed J; Charytan C; Yee J
    Consult Pharm; 2007 Mar; 22(3):230-8. PubMed ID: 17658969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron supplementation enhances response to high doses of recombinant human erythropoietin in preterm infants.
    Carnielli VP; Da Riol R; Montini G
    Arch Dis Child Fetal Neonatal Ed; 1998 Jul; 79(1):F44-8. PubMed ID: 9797624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin.
    Stoves J; Inglis H; Newstead CG
    Nephrol Dial Transplant; 2001 May; 16(5):967-74. PubMed ID: 11328902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance and efficacy of intravenous iron saccharate for iron deficiency anemia in children and adolescents receiving long-term parenteral nutrition.
    Michaud L; Guimber D; Mention K; Neuville S; Froger H; Gottrand F; Turck D
    Clin Nutr; 2002 Oct; 21(5):403-7. PubMed ID: 12381338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
    Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
    Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis.
    Silverberg DS; Iaina A; Peer G; Kaplan E; Levi BA; Frank N; Steinbruch S; Blum M
    Am J Kidney Dis; 1996 Feb; 27(2):234-8. PubMed ID: 8659499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of anaemia in inflammatory bowel disease with iron sucrose.
    Bodemar G; Kechagias S; Almer S; Danielson BG
    Scand J Gastroenterol; 2004 May; 39(5):454-8. PubMed ID: 15180183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion.
    Kooistra MP; Kersting S; Gosriwatana I; Lu S; Nijhoff-Schutte J; Hider RC; Marx JJ
    Eur J Clin Invest; 2002 Mar; 32 Suppl 1():36-41. PubMed ID: 11886430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Prevalence of Iron Deficiency Despite Standardized High-Dose Iron Supplementation During Recombinant Erythropoietin Therapy in Extremely Low Gestational Age Newborns.
    Siddappa AM; Olson RM; Spector M; Northrop E; Zamora T; Brearley AM; Georgieff MK; Rao R
    J Pediatr; 2020 Jul; 222():98-105.e3. PubMed ID: 32418819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration.
    Parkkinen J; von Bonsdorff L; Peltonen S; Grönhagen-Riska C; Rosenlöf K
    Nephrol Dial Transplant; 2000 Nov; 15(11):1827-34. PubMed ID: 11071973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of serum ferritin and transferrin saturation values associated with two i.v. iron formulations in hemodialysis patients.
    Nguyen TV
    Am J Health Syst Pharm; 2009 Jun; 66(12):1101-4. PubMed ID: 19498125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial.
    Kochhar PK; Kaundal A; Ghosh P
    J Obstet Gynaecol Res; 2013 Feb; 39(2):504-10. PubMed ID: 22925176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of iron deficiency anaemia in gynaecological patients at Jinnah Postgraduate Medical Centre, Karachi.
    Nasir A; Yasmin H; Korejo R
    J Pak Med Assoc; 2011 Oct; 61(10):998-1001. PubMed ID: 22356035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of i.v. iron saccharate in haemodialysis patients not responding to oral iron and erythropoietin.
    al-Hawas F; Abdalla AH; Popovich W; Mousa DH; al-Sulaiman MH; al-Khader AA
    Nephrol Dial Transplant; 1997 Dec; 12(12):2801-2. PubMed ID: 9430909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.